CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
-9.55%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$6.91B
AUM Growth
+$6.91B
(-11%)
Cap. Flow
-$3.91M
Cap. Flow
% of AUM
-0.06%
Top 10 Holdings %
Top 10 Hldgs %
70.94%
Holding
141
New
10
Increased
20
Reduced
68
Closed
19
Top Buys
| 1 |
American Tower
AMT
|
$337M |
| 2 |
Procter & Gamble
PG
|
$48.4M |
| 3 |
CVS Health
CVS
|
$36.9M |
| 4 |
US Bancorp
USB
|
$36.2M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$11M |
Top Sells
| 1 |
Citigroup
C
|
$355M |
| 2 |
Colgate-Palmolive
CL
|
$27M |
| 3 |
Visa
V
|
$18.3M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
$9.59M |
| 5 |
Bristol-Myers Squibb
BMY
|
$7.46M |
Sector Composition
| 1 | Financials | 22.69% |
| 2 | Consumer Discretionary | 16.64% |
| 3 | Healthcare | 14.3% |
| 4 | Communication Services | 12.68% |
| 5 | Consumer Staples | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Toronto Dominion Bank
TD
$128B
| $2.12M | 0.03% |
31,209
+12,166
| +64% | +$826K |
|
77
Insulet
PODD
$24.2B
| $2.06M | 0.03% |
25,994
-9,221
| -26% | -$731K |
|
78
Iovance Biotherapeutics
IOVA
$800M
| $2.01M | 0.03% |
226,681
-173,922
| -43% | -$1.54M |
|
|
TVRD
79
Tvardi Therapeutics, Inc. Common Stock
TVRD
$270M
| $1.99M | 0.03% |
4,256
-2,617
| -38% | -$1.22M |
|
80
Progressive
PGR
$145B
| $1.95M | 0.03% |
32,374
+11,470
| +55% | +$692K |
|
81
Elevance Health
ELV
$72.4B
| $1.93M | 0.03% |
7,364
| – | – |
|
82
Aramark
ARMK
$10.2B
| $1.88M | 0.03% |
90,046
+33,843
| +60% | +$708K |
|
83
NeoGenomics
NEO
$1.06B
| $1.88M | 0.03% |
149,378
-52,993
| -26% | -$668K |
|
84
Viking Therapeutics
VKTX
$3.02B
| $1.78M | 0.03% |
+232,138
| New | +$1.78M |
|
|
ITCI
85
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.67M | 0.02% |
146,671
-52,032
| -26% | -$593K |
|
|
ONCE
86
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.63M | 0.02% |
41,624
-13,375
| -24% | -$523K |
|
87
Franco-Nevada
FNV
$36.6B
| $1.6M | 0.02% |
22,759
+8,000
| +54% | +$561K |
|
|
FOMX
88
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.59M | 0.02% |
442,884
-157,116
| -26% | -$564K |
|
89
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $1.54M | 0.02% |
170,525
-57,371
| -25% | -$519K |
|
90
Insmed
INSM
$30.3B
| $1.48M | 0.02% |
113,110
-127,532
| -53% | -$1.67M |
|
|
STOR
91
DELISTED
STORE Capital Corporation
STOR
| $1.43M | 0.02% |
50,360
| – | – |
|
92
Open Text
OTEX
$8.37B
| $1.4M | 0.02% |
31,454
| – | – |
|
93
Acadia Healthcare
ACHC
$2.15B
| $1.38M | 0.02% |
53,712
-19,055
| -26% | -$490K |
|
|
VCRA
94
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $1.38M | 0.02% |
35,013
-23,332
| -40% | -$918K |
|
|
AXDX
95
DELISTED
Accelerate Diagnostics
AXDX
| $1.32M | 0.02% |
11,468
-4,069
| -26% | -$468K |
|
|
STML
96
DELISTED
Stemline Therapeutics, Inc.
STML
| $1.26M | 0.02% |
132,428
-46,981
| -26% | -$446K |
|
|
CLVS
97
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.23M | 0.02% |
68,492
-22,664
| -25% | -$407K |
|
98
Aclaris Therapeutics
ACRS
$223M
| $1.13M | 0.02% |
152,954
-52,797
| -26% | -$390K |
|
|
PFNX
99
DELISTED
Pfenex Inc.
PFNX
| $1.12M | 0.02% |
352,153
| – | – |
|
100
Allstate
ALL
$53.9B
| $1.12M | 0.02% |
+13,537
| New | +$1.12M |
|